dark
Invidious

3:55

OncoPower Trodelvy (sacituzumab govitecan-hziy) and what are its side effects? | OncoPower

OncoPower

Shared 4 years ago

2.3K views

5:22

Integrating Sacituzumab and Pembrolizumab into Breast cancer treatment

OncUpdates: Latest Oncology Insights

Shared 3 months ago

907 views

1:24

TRODELVY (sacituzumab govitecan-hziy)- Breast cancer

Pharmacy Talk USA

Shared 2 years ago

352 views

20:04

Datopotamab Deruxtecan vs Sacituzumab Govitecan Explained - Dr. Bill Gradishar & Dr. Tiffany Traina

Community Health Media

Shared 3 months ago

90 views

20:49

關於ADC藥物-Sacituzumab govitecan(拓達維/Trodelvy) 於乳癌治療的應用剖析-1/4

陳駿逸醫師與您癌歸於好

Shared 1 year ago

274 views

16:18

關於ADC藥物-Sacituzumab govitecan(拓達維/Trodelvy) 於乳癌治療的應用剖析-3/4

陳駿逸醫師與您癌歸於好

Shared 1 year ago

214 views

8:58

關於ADC藥物-Sacituzumab govitecan(拓達維/Trodelvy) 於乳癌治療的應用剖析-4/4

陳駿逸醫師與您癌歸於好

Shared 1 year ago

192 views

3:40

Dr. Rebecca Shatsky on the Top Breakthroughs in TNBC at ASCO 2025

Breast Cancers Today

Shared 10 months ago

186 views

15:40

關於ADC藥物-Sacituzumab govitecan(拓達維/Trodelvy) 於乳癌治療的應用剖析-2/4

陳駿逸醫師與您癌歸於好

Shared 1 year ago

88 views

3:16

Interpreting ASCENT-04 Findings With Dr. Sarah Tolaney

Breast Cancers Today

Shared 10 months ago

152 views

3:49

Navigating TROP2 ADC Options in PD-L1-Negative TNBC

OncUpdates: Latest Oncology Insights

Shared 3 months ago

1.7K views

6:33

Sacituzumab govitecan drug side effects #trodelvy #sacituzumab #stage4cancer

SurvivorMomRoma

Shared 1 month ago

7 views

5:14

How Antibody-Drug Conjugates Are Reshaping The Treatment Algorithm in Triple-Negative Breast Cancer

OncUpdates: Latest Oncology Insights

Shared 1 month ago

950 views

0:20

#Sacituzumab Govitecan #drug #medication #uses #medical #words #terms #dictionary #meanings #definit

Lingo Prism

Shared 2 years ago

1 view

1:07

Neutropenia Challenges in Sacituzumab Treatment - Discussing First-Cycle Toxicities

Oncology Perspectives

Shared 4 months ago

70 views

1:09

Oncologist Preferences for Hormone Receptor Positive Breast Cancer Treatment

Innovative Oncology News

Shared 1 month ago

68 views

0:48

#Trastuzumab emtansine (TDM1), #TDXd, #ADCs#Sacituzumab govitecan #datopotamab deruxtecan (Dato DXd)

EK DIN KA RAJA-PATHOLOGY NOTES

Shared 1 year ago

115 views

29:57

SABCS2021: Übersicht zur Therapie des triple-negativen Brustkrebs (TNCB), Prof. Untch

Brustkrebs Deutschland e.V.

Shared 4 years ago

4.4K views

10:57

SABCS2021: Brustkrebs triple-negativ - Neue Therapien mit Antikörpern, Prof. Müller

Brustkrebs Deutschland e.V.

Shared 4 years ago

1.4K views

22:34

治療三陰性乳癌的新藥物Sacituzumab govitecan(拓達維/Trodelvy)-1/2

陳駿逸醫師與您癌歸於好

Shared 1 year ago

262 views

16:03

治療三陰性乳癌的新藥物 Sacituzumab govitecan(拓達維/Trodelvy)-2/2

陳駿逸醫師與您癌歸於好

Shared 1 year ago

291 views

23:52

簡介第一個可用於荷爾蒙受體陽性晚期乳癌治療的Trop-2 ADC藥物-Sacituzumab govitecan(拓達維/Trodelvy)

陳駿逸醫師與您癌歸於好

Shared 1 year ago

292 views

11:52

Triple Negative Breast Cancer (TNBC): The Facts, How to know if you have it and how to treat it

Go 2 Health

Shared 3 years ago

45 views

30:07

2024年ASCO公告最新肺癌Trop-2 ADC 藥物Sacituzumab govitecan(拓達維/Trodelvy)用於第二線治療非小細胞肺癌的研究數據解析

陳駿逸醫師與您癌歸於好

Shared 1 year ago

290 views

3:59

ASCENT-03 Explained: Crossover, Control Arms, and Real-World Impact

Community Health Media

Shared 3 months ago

11 views

23:22

簡介第一個健保給付三陰性乳癌治療的ADC藥物-Sacituzumab govitecan(拓達維/Trodelvy)

陳駿逸醫師與您癌歸於好

Shared 2 years ago

867 views

20:43

2024年ASCO公告 TROP2 ADC藥物蘆康沙妥珠單抗(Sacituzumab tirumotecan)用於既往未接受過治療晚期非小細胞肺癌患者的最新研究數據解析

陳駿逸醫師與您癌歸於好

Shared 1 year ago

447 views

14:04

小細胞肺癌治療新進展的整理 (上)

陳駿逸醫師與您癌歸於好

Shared 1 year ago

816 views

1:07:42

反向思考與創新製藥 讓HER-2陰性乳癌揮別陰霾

陳駿逸醫師與您癌歸於好

Shared 3 years ago

342 views

24:02

小細胞肺癌治療新進展的整理 (下)

陳駿逸醫師與您癌歸於好

Shared 1 year ago

660 views

5:45

乳此美麗俱樂部-2021看三陰性乳癌的最新治療策略 下集

癌症新觀點

Shared 4 years ago

1K views

27:55

當乳癌標靶CDK4/6治療出現抗藥性時 新型ADC藥物sacituzumab govitecan(商品名Trodelvy) 如何接續?

陳駿逸醫師與您癌歸於好

Shared 2 years ago

2.4K views

15:30

Trodelvy(拓達維)結盟免疫 治療非小細胞肺癌EVOKE-02研究的整理

陳駿逸醫師與您癌歸於好

Shared 2 years ago

266 views

18:56

解析管腔型乳癌荷爾蒙治療的抗藥機制與治療的新進展(上集)

陳駿逸醫師與您癌歸於好

Shared 2 years ago

2.4K views

25:23

優赫得是否為三陰性晚期乳癌治療的新選擇呢?

陳駿逸醫師與您癌歸於好

Shared 2 years ago

234 views

17:01

新型ADC-Trodelvy(拓達維)治療轉移性乳癌的整理

陳駿逸醫師與您癌歸於好

Shared 2 years ago

856 views

Original source code / Modified source code Documentation
Released under the AGPLv3 on GitHub. View JavaScript license information. View privacy policy.
Services Forum Donate @ Tiekoetter.com Donate @ Invidious.io Current version: 2026.03.13-ab76e29e @ master
Contact: tinbox@tiekoetter.com